Chronic Myeloproliferative Disorders: Clinical Trials

2 trials for Chronic Myeloproliferative Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Chronic Myeloproliferative Disorders: new trials by email Literature Review of Chronic Myeloproliferative Disorders trials Research Report on Chronic Myeloproliferative Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Pemetrexed - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Early Phase 1CompletedNorthwestern University152007-01-012021-09-08
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
PS-341 - Chronic Myeloproliferative Disorders, Leukemia
Early Phase 1CompletedMayo Clinic302005-09-012014-10-17

Narrower conditions

Leukemia (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Myeloproliferative Disorders (2)  ·  Primary Myelofibrosis (2)  ·  Blast Crisis (1)  ·  Brain Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Central Nervous System Neoplasms (1)  ·  Congenital Abnormalities (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia, Myeloid (2)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Amyloidosis (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Blood Protein Disorders (1)

Interventions

Bortezomib (1)  ·  Pemetrexed (1)

Sponsors

Mayo Clinic (1)  ·  Northwestern University (1)

Countries

United States (2)

Top investigators

Candido E. Rivera, M.D. (1)  ·  Jeffrey J. Raizer, MD (1)  ·  Ruben A. Mesa, M.D. (1)

NIH funding

P30CA015083 (1)